Novartis AGNVSNYSE
Loading
EPS Diluted Over TimeExpanding
Percentile Rank86
3Y CAGR+31.4%
5Y CAGR+15.4%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
+31.4%/yr
vs -12.4%/yr prior
5Y CAGR
+15.4%/yr
Recent acceleration
Acceleration
+43.8pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
20257.19+22.5%
20245.87-17.3%
20237.10+124.0%
20223.17-70.2%
202110.63+202.0%
20203.52+14.3%
20193.08-42.8%
20185.38+65.5%
20173.25+16.1%
20162.80-